Tag: Global registrational Phase III study

global-registrational-phase-iii-study-of-olverembatinib-for-the-treatment-of-patients-with-sdh-deficient-gist-approved-by-the-china-cde-thailand-business-news

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient...

Ascentage Pharma, a global biopharmaceutical company, has received approval from the Center for Drug Evaluation (CDE) of China’s National Medical Product Administration (NMPA) for...